November 17th, 2015|
Drug manufacturer, Johnson & Johnson, has come under fire for failing to warn patients about the risks associated with their medication, Risperdal®. Now, the company has been ordered to pay millions of dollars to one patient who suffered adverse health effects as a result of taking the drug.
In 2004, Risperdal® was approved to treat a variety of mental disorders in adult patients. However, the maker of the drug began to market the medication to children shortly thereafter.
The results were that many young patients developed Gynecomastia—a condition in which males develop excessive amounts of breast tissue that can require corrective surgery. Many of the victims of Risperdal® side effects have now successfully filed lawsuits against Johnson & Johnson claiming they were not warned of the risks associated with the drug.
Court documents show Johnson & Johnson has been ordered to pay $1.8 million to a 21-year-old Maryland man who developed Gynecomastia as a result of using Risperdal®. A report from Bloomberg News says this is the third verdict to come in favor of those who have lawsuits after suffering adverse side effects from taking Risperdal®. A filing with the U.S. Securities and Exchange Commission indicates the company could be facing as many as 5,400 similar suits in the future.
Taking legal action can be an effective way for citizens to hold drug manufacturers accountable for their products. The legal staff at Ferrer, Poirot & Wansbrough is hopeful the drug injury lawsuits and settlements that have been filed in connection to Risperdal® and Gynecomastia will bring closure to those who have been harmed.
November 3rd, 2015|
Companies that manufacture medications are required to thoroughly test their product to help reduce the risk of serious drug injuries. But sometimes, dangerous drugs are released to patients.
The U.S. Food and Drug Administration (FDA) recently issued warnings about the serious risks related to two different Hepatitis C drugs. Officials linked used of the medications to serious liver damage in some patients.
Viekira Pak and Technivie were both approved to treat the symptoms of the viral disease in Dec. 2014. Since that time, the FDA has received 26 reports of patients suffering serious liver damage. The Washington Post reports some patients died as the result of their injuries, while others had to undergo corrective treatments and procedures—including liver transplants.
The FDA is encouraging users to be on the lookout for signs of liver damage, such as loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes. Patients are also being urged to continue using the medications unless instructed otherwise by your physician.
If you’ve been harmed as the result of taking either Viekira Pak or Technivie, it’s important to know you may have a drug injury lawsuit. Learn more about the options and resources available to drug injury victims by visiting our website.
January 6th, 2015|
Xarelto® is a blood thinner once lauded as a revolutionary treatment for stroke and heart attack victims because it required less monitoring by medical staff. However, the drug was found to increase the risk of uncontrolled bleeding in certain patients.
Some bleeding injury victims have gone on to file Xarelto lawsuits against Johnson & Johnson, the maker of the drug. And now these cases have taken another step forward in the legal process.
Injury Lawyer News reports that a judicial panel has decided the Xarelto lawsuits should be consolidated. This means the roughly 21 Xarelto lawsuits filed in as many as 10 federal courts will be examined during a single trial in the Eastern District of Louisiana with U.S. District Judge Eldon E. Fallon presiding.
The cases were consolidated after it was determined that each of the lawsuits were based on claims. Attorneys for Xarelto injury victims argue Johnson & Johnson failed to provide enough warning of the dangers associated with the bleeding risks posed to users.
At Ferrer, Poirot & Wansbrough, we know the struggles Xarelto drug injury victims are facing, and our drug injury lawyers are here to help if you or a loved one was the victim of a Xarelto bleeding injury. Dial (800) 210-8503 to contact our 24/7 legal team now.
December 16th, 2014|
Each year thousands of patients are harmed as the result of being administered drugs that were contaminated due to poor handling or manufacturing processes.
One such case resulted in a drug injury lawsuit against the hospital responsible for allegedly giving the victim a dose of a contaminated drug that led to their development of serious health complications.
According to an article from CBS Miami News, the Brevard County hospital was sued after a bypass surgery patient was given a dose of blood thinner contaminated with bacteria. This led to an infection that ultimately resulted in the amputation of the patient’s legs. The victim contends the hospital was made aware of a recall of the contaminated drug, but failed to take action.
The hospital argued the claims should be handled as a medical malpractice case, but a panel of judges recently ruled the case should be heard as-is.
At Ferrer, Poirot & Wansbrough, we are aware of the serious harm caused by contaminated patients. That’s why our drug injury lawyers are hopeful a decision in this case will help bring a sense of closure to the victim.
December 9th, 2014|
When a patient is harmed as the result an unsafe or recalled drug, they may be entitled to seek compensation for damages by filing a drug injury lawsuit. There are several steps to the multidistrict litigation (MDL) process through which many drug injury and defective medical device claims are handled.
Your attorney files your claim after gathering evidence related to your drug injury. Once your case is consolidated alongside other similar claims related to the same drug, the case will proceed through three steps:
- Discovery- This is an opportunity for plaintiffs’ attorneys and drug company lawyers to exchange information so that both sides can thoroughly consider and understand all aspects of the case.
- Pretrial- After gathering all the necessary information, both sides present their case to a single judge assigned to the MDL.
- Settlement Conferences- After hearing arguments, the judge will attempt to mediate a settlement between the plaintiffs’ attorneys assigned to the MDL and the drug company lawyers. If a settlement is reached, each plaintiff receives a settlement based upon his or her injuries. If an agreement cannot be reached between the two sides, individual cases are sent back to the courts where they were filed for trial.
At Ferrer, Poirot & Wansbrough, we understand how drug injuries affect victims’ lives. That’s why our drug injury attorneys are here to answer any questions you may have if you or a loved one has been harmed as the result of a recalled or dangerous drug. Call us to learn more about how we can help at (800) 210-8503.